Skip to content
Peptigraph home

5-Amino-1MQ

NNMT inhibitor (not a peptide). 5-Amino-1MQ is not FDA approved for any use.

Also called:5-amino1MQ
Medically reviewed by Juan Pablo Frías, MD · · DisclosureUpdated Strongest evidence: Animal evidence, 2 of 4
StatusNot FDA approved · research chemicalWADA status unclearFull legal history

Key facts

Class
NNMT inhibitor (not a peptide)
Not a peptide
Also called
5-amino, 1MQ
Vial sizes sold
5 mg, 10 mg
Community-reported sizes
Half-life
Not found
No published half-life found (PubMed search, 11 Oct 2026)
FDA status
Not approved
research chemical
WADA
Unclear
Not named on the 2026 list
Everything on 5-Amino-1MQ

5-Amino-1MQ guides

Evidence at a glance

Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.

5-Amino-1MQ: studies by condition
ConditionHuman studiesAnimal studiesStudies we summarisedEvidence grade
Weight lossNot in our ledgerNot in our ledger1Animal evidence, 2 of 4Scientific reports 2022, PMID 35013352

Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.

Not a peptide at all

5-amino-1MQ is 5-amino-1-methylquinolinium, a small molecule that inhibits the enzyme nicotinamide N-methyltransferase (NNMT). It is not a peptide.[3]

The quinolinium scaffold behind it was identified by enzyme screening, with NNMT inhibition at an IC50 of about 1 μM.[7]

What research exists

The one weight study is in diet-induced obese mice: the inhibitor combined with a low-fat diet promoted weight loss, so the diet change is part of that result.[3]

Other work is in cell lines: 5MQ reduced HeLa cell proliferation without apparently affecting HEK-293 cells. These cell results are unrelated to weight.[8]

A cell paper reports reduced viability and increased apoptotic signalling in cancer cells treated with NNMT inhibitors.[9]

Regulatory path

The Drugs@FDA search for 5-amino-1MQ returned no match, so no approved product exists.[2]

Compared with

Common stacks

5-Amino-1MQ is often sold pre-mixed or combined with other peptides. No controlled study has tested these combinations; the pages below cover the math and what each part has been studied for.

Common questions

Is 5-Amino-1MQ FDA approved?

No. 5-Amino-1MQ is not FDA approved for any use.

Is 5-Amino-1MQ a peptide?

No. It is a nnmt inhibitor. It is listed here because people research it alongside peptides.

How much water goes in a 10 mg vial?

That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.

What is 5-amino-1MQ?

A small-molecule NNMT inhibitor, 5-amino-1-methylquinolinium.[3]

What does 5-amino-1MQ do?

In obese mice it promoted weight loss when combined with a low-fat diet; no human data were found.[3]

Is there an oral 5-amino-1MQ?

No approved 5-amino-1MQ product exists in any form, oral included: the FDA search returned no match, and no human study was found.[2]

Is there a 5-amino-1MQ clinical trial in humans?

A ClinicalTrials.gov API search for 5-amino-1-methylquinolinium or 5-amino-1MQ returned a total of 0 registered studies.[10]

What has the FDA said about 5-amino-1MQ?

Drugs@FDA returned no matches for the compound, and this site's cached FDA compounding and warning-letter records do not mention it.[2]

What is the half-life of 5-amino-1MQ?

A PubMed search on 2026-10-25 combining the compound's names with pharmacokinetic and half-life terms found 0 records, so this site has no half-life to report.[11]

Sources

  1. 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
  2. 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "5-amino-1MQ" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
  3. 3Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.Scientific reports · 2022PMID 35013352Accessed 2 Oct 2026
  4. 4PubMed search: "5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab] (3 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  5. 5PubMed search: nicotinamide N-methyltransferase[tiab] AND (quinolinium[tiab] OR 5-amino-1MQ[tiab] OR "5-amino-1-methylquinolinium"[tiab] OR 5MQ[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
  6. 6PubMed search: ("5-amino-1MQ"[tiab] OR "5-amino-1-methylquinolinium"[tiab]) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (0 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
  7. 7Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase.Journal of medicinal chemistry · 2017PMID 28548833Accessed 2 Oct 2026
  8. 8Small molecule inhibitor of nicotinamide N-methyltransferase shows anti-proliferative activity in HeLa cells.Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology · 2021PMID 33645410Accessed 2 Oct 2026
  9. 9Small Molecule Inhibitors of Nicotinamide N-Methyltransferase Enzyme for the Treatment of Osteosarcoma and Merkel Cell Carcinoma: Potential for the Development of a Targeted Therapeutic Strategy.Biomolecules · 2025PMID 41301471Accessed 2 Oct 2026
  10. 10clinicaltrials.gov: term 5-amino-1-methylquinolinium OR 5-amino-1MQClinicalTrials.gov · 2026clinicaltrials.govAccessed 25 Oct 2026
  11. 11Official web pageOfficial web page · web page

Found an error? Report a correction.